Toronto Dominion Bank purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 75,000 shares of the company's stock, valued at approximately $1,008,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC lifted its stake in Oscar Health by 171.4% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock worth $89,000 after purchasing an additional 4,185 shares in the last quarter. KBC Group NV raised its holdings in Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after purchasing an additional 2,555 shares in the last quarter. Alberta Investment Management Corp purchased a new position in shares of Oscar Health during the fourth quarter worth about $138,000. Virtu Financial LLC purchased a new position in shares of Oscar Health during the fourth quarter worth approximately $140,000. Finally, Potentia Wealth purchased a new stake in shares of Oscar Health in the fourth quarter valued at about $141,000. Hedge funds and other institutional investors own 75.70% of the company's stock.
Oscar Health Stock Up 6.1%
OSCR stock traded up $0.86 during mid-day trading on Tuesday, hitting $15.03. The stock had a trading volume of 8,061,517 shares, compared to its average volume of 4,326,542. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.79. The company has a fifty day moving average of $13.68 and a 200 day moving average of $14.59. The stock has a market capitalization of $3.77 billion, a price-to-earnings ratio of -751.12 and a beta of 1.75. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. The business had revenue of $3 billion during the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The firm's revenue for the quarter was up 42.2% on a year-over-year basis. During the same quarter last year, the company posted $0.62 EPS. On average, equities analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.
Insider Buying and Selling
In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director now directly owns 64,512 shares in the company, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 24.39% of the stock is owned by insiders.
Analyst Ratings Changes
A number of equities research analysts have weighed in on the company. Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price objective for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Wall Street Zen lowered shares of Oscar Health from a "buy" rating to a "hold" rating in a report on Thursday, May 22nd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $20.08.
Get Our Latest Stock Analysis on Oscar Health
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
